Featured
Richard L. Trumka, President, AFL-CIO announced an update to their PayWatch website—this year’s version is called CEO Pay and the 99%. Trumka says it’s your one-stop shop for the most recent information on out-of-control CEO pay and what you can …
Continue reading
Oxytocin The neurochemical of pair-bonding, love, and trust which mediates financial decisions, and most others as well, is a mammalian hormone and neuromodulator called oxytocin. French scientist Vincent du Vigneaud was fast tracked for the Nobel Prize in 1955 just …
Continue reading
Bank of America executives, investors, and opponents alike reacted with surprise to news—posted for two hours on Dow Jones Newswire and elsewhere—that the mammoth financial institution, realizing it was heading for a taxpayer bailout, was asking Americans to start thinking about …
Continue reading
Science Rules! Fantastic developments in neuroscience, behavioral finance, and neuroeconomics have occurred during the past thirty plus years. Brain chemistry and money behavior are inexorably in synch! Emotions and brain chemistry mediate everything that happens within us, between us (our …
Continue reading
Investing in Japan by Steven Towns carries the subtitle, “There is no stock market as undervalued and as misunderstood as Japan.” Towns might be right. He guides the reader to plenty of undervalued companies but will their underlying value be eventually …
Continue reading
Sustainability Shareholders consider sustainability of the companies they co-own a primary need, a right, and, frankly, an “entitlement.” It would seem reasonable that managers and employees would feel essentially the same. If the companies we’ve all invested in go belly …
Continue reading
The Securities and Exchange Commission recently announced the formation of its new Investor Advisory Committee required by the Dodd-Frank Wall Street Reform and Consumer Protection Act. The 21-member committee replaced the advisory committee that was disbanded after the Dodd-Frank Act …
Continue reading
Sustainability of the companies we co-own can only be enhanced and bolstered by rules of engagement which aspire to consummate professionalism. Trading is at the heart of many Wall Street firms. What follows are techniques guidelines, ideals, and suggestions which can inspire …
Continue reading
This slim publication for directors, as always, is jammed with tips. While all were informative (Ward’s publication is one of a few where I generally read every article), a few jumped out: Ward recommends that directors go to Facebook and …
Continue reading
Jamie Dimon is an industry superstar. In a recent Vanity Fair article William Cohan proclaimed him “King of Wall Street.” Mr. Dimon is widely respected among his peers. I believe Mr. Cohan feels that Jamie Dimon is a modern day …
Continue reading
Subscribe to The
Wall Street Psychologist
About Christopher Bayer, Ph.D.
Co-founder of TheShareholderActivist.comTM, Christopher Bayer, Ph.D., is "The Wall Street Psychologist." With his weekly blogs, research and special features, Dr. Bayer brings you inside the minds of The Street as few can.
Since the early 1980's, Dr. Bayer has practiced as a licensed New York psychologist and psychoanalyst, specializing in the treatment of financial services executives in the securities and banking industries. He has a long standing interest in shareholder education and shareholder activism.
read more...
Fundamentals
The Shareholder Activist's Mission
The Shareholder Activist is a network that empowers investors to exercise their rights as equity stakeholders. Our goal is to create a platform for responsible shareholder activism ensuring the viability and sustainability of companies we co-own. As an online community we provide tools, tactics, and techniques to hold companies to their stated mission. We advocate for shareholder and investor education.